SMAD2 and adrenal cortex carcinoma: We found that suppression of TGF-β signaling by the inhibitor reduced Smad2 phosphorylation level and down-regulated Vimentin expression (Figure 5B right), without affecting the morphologic and molecular features of c-kit-expressing ACC-M cells undergoing EMT.